Gimv — 2022 Investments
2 investments dated 2022 · listed companies and verified rows first · show all
BioConnection is a Contract Development and Manufacturing Organization (CDMO) specializing in filling, finishing, and lyophilizing injectable biopharmaceutical products.
Advanced ManufacturingBiotechHealthtechMedical DevicesOss, NL
Co-investorsBOM
JenaValve develops transcatheter aortic valve replacement systems to treat severe aortic regurgitation and aortic stenosis.
Digital HealthHealthtechMedical DevicesIrvine, US
Hans Figulla(Director)Markus FerrariVictoria Carr-Brendel(Executive Officer, Director)David Drachman(Executive Officer, Director)John Kilcoynein
BoardArnd Kaltofen(Director)in
Co-investorsAndera PartnersBain Capital Life SciencesRosetta Capital Ltd.VI PartnersAtlas VentureInnovatus Capital Partners+5 more
Rows marked “SEC filing” are inferred from directors named on the company's SEC Form D — public regulatory data, not a portfolio list published by the firm.



.jpg)



